Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

317
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
317
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Expert viewpoint on endpoints in systemic sclerosis: current and future outlook.

RMD open·2026
Same author

Patient reports of evaluations for interstitial lung disease in patients with connective tissue diseases and rheumatoid arthritis: an international survey.

Respiratory research·2026
Same author

Lung disease in rheumatoid arthritis.

Nature reviews. Rheumatology·2026
Same author

Visual analysis of [<sup>18</sup>F]FDG PET/CT imaging yields superior diagnostic accuracy compared to semiquantitative analysis in the assessment of giant cell arteritis.

European journal of nuclear medicine and molecular imaging·2026
Same author

Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR database.

European journal of internal medicine·2026
Same author

Serum KL-6 and lung ultrasound B-lines: a combined non-invasive model for screening and predicting interstitial lung disease in idiopathic inflammatory myopathy.

RMD open·2026

相关实验视频

Updated: Jul 14, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.0K

系统性硬化症中持续性炎症的表型:与系统性硬化症相关的间歇性肺病:EUSTAR数据库分析.

Sabina Guler1,2, Adela-Cristina Sarbu3, Odile Stalder4

  • 1Department of Pulmonary Medicine, Inselspital University Hospital Bern, Bern, Switzerland Sabina.Guler@insel.ch.

Thorax
|October 5, 2023
PubMed
概括

系统性硬化与持续性炎症显著增加SSc-ILD患者的死亡风险. 早期的免疫抑制治疗在系统性硬化症的炎症表型中稳定了肺功能.

关键词:
间歇性纤维化 间歇性纤维化类风湿性肺部疾病 类风湿性肺部疾病系统性疾病和肺部疾病

更多相关视频

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

482
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
08:16

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

Published on: July 7, 2017

7.5K

相关实验视频

Last Updated: Jul 14, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.0K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

482
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
08:16

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

Published on: July 7, 2017

7.5K

科学领域:

  • 类风湿病学 类风湿病学
  • 肺部病理学 肺部病理学
  • 免疫学 免疫学 免疫学

背景情况:

  • 系统性硬化症 (SSc) 是一种复杂的自身免疫性疾病.
  • 间歇性肺病 (SSc-ILD) 是SSc的常见和严重并发症.
  • 炎症在SSc病原和进展中起着至关重要的作用.

研究的目的:

  • 根据炎症水平评估表型化SSc和SSc-ILD患者的预后价值.
  • 通过炎症状态和免疫抑制治疗分层的SSc和SSc-ILD中描述疾病轨迹.

主要方法:

  • 利用了来自欧洲硬质皮肤病试验和研究 (EUSTAR) 队列的数据.
  • 根据C-反应蛋白 (CRP) 水平,将患者分为持续炎症,中间和非炎症表型.
  • 在死亡风险分析中采用考克斯回归和在FVC和DLCO轨迹分析中采用混合效应模型.

主要成果:

  • 患有SSc-ILD和持久炎症表型的患者与非炎症表型相比,面临5年死亡风险6.7倍.
  • 在炎症表型中,强迫生命能力 (FVC) 在没有治疗的情况下下降,但在免疫抑制疗法下稳定.
  • 非炎症性表型的FVC下降,在接受免疫抑制治疗的患者中观察到更明显的下降.

结论:

  • 通过持久性炎症进行表型化,可以提供SSc和SSc-ILD的显著预后见解,独立于其他临床因素.
  • 建议早期免疫抑制治疗SSc-ILD患者表现出持续性炎症.
  • 基于炎症的表型可以指导治疗决策并改善SSc-ILD的结果.